Literature DB >> 22639406

Use of matrix assisted laser desorption ionisation-time of flight mass spectrometry in a paediatric clinical laboratory for identification of bacteria commonly isolated from cystic fibrosis patients.

Ankita Patel Desai1, Theresa Stanley, Maria Atuan, Jonelle McKey, John J Lipuma, Beverly Rogers, Robert Jerris.   

Abstract

BACKGROUND: Matrix-assisted laser desorption ionisation-time of flight mass spectrometry (MALDI-TOF MS) has been described as a rapid, accurate method for bacterial identification. AIMS: To investigate the ability of the technique, using the unamended database supplied with the system, to identify bacteria commonly isolated in cystic fibrosis (CF) patients.
METHODS: Organisms commonly isolated from CF patients identified by MALDI-TOF MS were compared to conventional phenotypic and genotypic analyses. For MALDI-TOF MS, the direct colony technique was used routinely with one extraction procedure performed on a mucoid Pseudomonas aeruginosa. For 24 unique CF specimens, workload comparison and time to identification were assessed.
RESULTS: Of 464 tested isolates, conventional (phenotypic and genotypic) identification compared to MALDI-TOF MS showed complete genus, species agreement in 92%, with genus agreement in 98%. This included 29 isolates within the Burkholderia cepacia complex. All 29 were correctly identified to the genus level and 24 of these were speciated. Time to identification with 47 bacterial isolates from 24 CF patients showed identification of 85% of isolates by MALDI-TOF MS at 48 h of incubation, compared to only 34% with conventional methods.
CONCLUSIONS: Using the unamended database supplied with the system, MALDI-TOF MS provides rapid and reliable identification of bacteria isolated from CF specimens. Time to identification studies showed that the use of same day, same method for organism identification will decrease time to result and optimise microbiology workflow.

Entities:  

Mesh:

Year:  2012        PMID: 22639406     DOI: 10.1136/jclinpath-2012-200772

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

Review 1.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology.

Authors:  Andrew E Clark; Erin J Kaleta; Amit Arora; Donna M Wolk
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  Comparison of matrix-assisted laser desorption ionization-time of flight (maldi-tof) mass spectrometry platforms for the identification of gram-negative rods from patients with cystic fibrosis.

Authors:  Kevin Alby; Peter H Gilligan; Melissa B Miller
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

3.  Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli.

Authors:  R Manji; M Bythrow; J A Branda; C-A D Burnham; M J Ferraro; O B Garner; R Jennemann; M A Lewinski; A B Mochon; G W Procop; S S Richter; J A Rychert; L Sercia; L F Westblade; C C Ginocchio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-10       Impact factor: 3.267

4.  Optimization of routine identification of clinically relevant Gram-negative bacteria by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and the Bruker Biotyper.

Authors:  Bradley A Ford; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2013-02-20       Impact factor: 5.948

5.  Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates.

Authors:  Lucie Amoureux; Julien Bador; Sakina Fardeheb; Cédric Mabille; Charlyne Couchot; Clémence Massip; Anne-Lise Salignon; Guillaume Berlie; Véronique Varin; Catherine Neuwirth
Journal:  Appl Environ Microbiol       Date:  2013-09-13       Impact factor: 4.792

6.  Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis.

Authors:  Florence Le Gall; Rozenn Le Berre; Sylvain Rosec; Jeanne Hardy; Stéphanie Gouriou; Sylvie Boisramé-Gastrin; Sophie Vallet; Gilles Rault; Christopher Payan; Geneviève Héry-Arnaud
Journal:  BMC Microbiol       Date:  2013-06-21       Impact factor: 3.605

7.  Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis.

Authors:  Atqah AbdulWahab; Saad J Taj-Aldeen; Emad Bashir Ibrahim; Eman Talaq; Marawan Abu-Madi; Rashmi Fotedar
Journal:  Infect Drug Resist       Date:  2015-04-30       Impact factor: 4.003

Review 8.  Mass spectrometry for the detection of potential psychiatric biomarkers.

Authors:  Armand G Ngounou Wetie; Izabela Sokolowska; Kelly Wormwood; Katherine Beglinger; Tanja Maria Michel; Johannes Thome; Costel C Darie; Alisa G Woods
Journal:  J Mol Psychiatry       Date:  2013-06-05

9.  Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment.

Authors:  Cynthia Santamaria; Eric Chatelain; Yves Jackson; Qianqian Miao; Brian J Ward; François Chappuis; Momar Ndao
Journal:  BMC Infect Dis       Date:  2014-06-03       Impact factor: 3.090

Review 10.  Molecular detection of CF lung pathogens: current status and future potential.

Authors:  Sally H Pattison; Geraint B Rogers; Martin Crockard; J Stuart Elborn; Michael M Tunney
Journal:  J Cyst Fibros       Date:  2013-02-10       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.